Effects of triple therapy on disease burden in patients of GOLD groups C and D: results from the observational COPD cohort COSYCONET

Effects of triple therapy on disease burden in patients of GOLD groups C and D: results from the observational COPD cohort COSYCONET

Abstract Background Randomized controlled trials described beneficial effects of inhaled triple therapy (LABA/LAMA/ICS) in patients with chronic obstructive pulmonary disease (COPD) and high risk of exacerbations. We studied whether such effects were also detectable under continuous treatment in a r...

Full description

Bibliographic Details
Main Authors: Jennifer A. Zader, Rudolf A. Jörres, Imke Mayer, Peter Alter, Robert Bals, Henrik Watz, Pontus Mertsch, Klaus F. Rabe, Felix Herth, Franziska C. Trudzinski, Tobias Welte, Hans-Ulrich Kauczor, Jürgen Behr, Julia Walter, Claus F. Vogelmeier, Kathrin Kahnert
Format: Article
Language:English
Published: BMC 2024-03-01
Series:BMC Pulmonary Medicine
Subjects:
COPD
Triple therapy
Symptoms
Lung function
Health care costs
Online Access:https://doi.org/10.1186/s12890-024-02902-4

Internet

https://doi.org/10.1186/s12890-024-02902-4

Similar Items